Bipolar vessel sealing system versus silk ligation of lymphatic vessels in renal transplant recipient lymphatic complications a Randomized controlled trial
Not Applicable
Recruiting
- Conditions
- Ongoing study
- Registration Number
- JPRN-UMIN000039354
- Lead Sponsor
- Institute of Medicine, Kathmandu
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 68
Inclusion Criteria
Not provided
Exclusion Criteria
Urinary leakage (drain creatine >2 times serum creatine Retroperitoneal hemorrhage Re exploration Mortality within 90 days
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ymphatic complications
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie lymphatic complications in renal transplantation using bipolar vessel sealing systems?
How does the effectiveness of bipolar vessel sealing compare to silk ligation for lymphatic vessel management in renal transplant recipients?
Are there specific biomarkers that identify patients at higher risk for lymphatic complications following renal transplantation?
What are the potential adverse events associated with bipolar vessel sealing in renal transplant surgery and how are they managed?
What alternative vessel sealing technologies or combination therapies are being explored for lymphatic complication prevention in renal transplantation?